Patient Perspective: Managing Ldl-C To Reduce Ascvd Risk

Patient Perspective: Managing LDL-C to Reduce ASCVD Risk

Cardiometabolic Health Congress (CMHC)

Looking Beyond LDL-C to Address ASCVD Risk

Cardiometabolic Health Congress (CMHC)

Management of Hyperlipidemia: 2018 ACC/AHA Guideline Update

Harvard Medical School Continuing Education

Innovative Lipid Management Strategies for ASCVD Risk Reduction

American Heart Association

Practical Insights of Cholesterol Guidelines for Secondary Prevention of ASCVD

American Heart Association

Managing Patients with High LDL Cholesterol or Familial Hypercholesterolemia

Lessons From an Academic Perspective - Sharing Ownership of Reducing ASCVD Risk

American Heart Association

A Real World Approach to LDL cholesterol using PCSK9 inhibitors, October 5 2018

Cardiology University of Washington

How Your Diet and Lifestyle Create Harmful LDL: The Hidden Truth #HeartHealth #LDLCholesterol

The Truth About Dietary Cholesterol | Dr. Peter Attia & Dr. Andrew Huberman

Huberman Lab Clips

Beyond LDL: Assessing and Treating Residual ASCVD Risk | Marc-Andre Cornier, MD

University of Colorado | Department of Medicine

High Cholesterol | What All Patients Need to Know

Statin Therapy for High-Risk Groups Summary Video

High Cholesterol: diet, medications, statin risks and benefits, ApoB and Lp(a), supplements more

LDL Cholesterol Lowering and CV Risk

Dyslipidemia Management & ASCVD Risk Reduction

Cardiometabolic Health Congress (CMHC)

LDL Cholesterol level: Your lab results explained

Nutrition Made Simple!

Secondary Prevention of Atherosclerotic Cardiovascular Disease & the Importance of LDL-C Management

American Heart Association

BEC 2021 | Аchieving target LDL-level in high risk patients with ASCVD | Ivo Petrov

Bulgarian Society for Endovascular Therapy

ESC Guidelines: Controlling Dyslipidemia (English Version)

CardioMinds, Dr. Sherif Altoukhy